Matt Holt

There's a whole set of vendors who have inserted data rights access into their contracts with those parties.

They will say by legal contract, they own and have access to data.

fundamentally, patients are the ones who have and should have the control of access to their own data.

And they should have ultimately the power and should be empowered to share their data with those stakeholders that they choose.

And ultimately, that speaks to there being a very big need for

you know, a framework to enable consent, where ultimately it's not the framework's job to make a decision on who owns the data.

It's the job of the framework to enable choice across the ecosystem.

And ultimately, that's going to be a fundamental leading point to unlocking a lot of the value that will get us to a more efficient and outcomes-based system.

We have a number of issues here which are preventing true interoperability.

Fundamentally, data is being moved from point A to point B to support one use case.

It's important to have an interoperable system to allow multiple use cases to sit on top of one underlying workflow.

So I think one of the unlocks will be

enabling multiple use cases across a consent network.

So that's number one.

Number two, the other fundamental attribute of data that exists in every other end market, but has been evasive in the healthcare market has been the fundamental concept of data reuse.

There's a lot of data that's moved from point A to point B to support one use case.

And then the data from there is no longer used.

Opening up a framework where I think you will need government intervention, but in partnership with market-based solutions to enable data reuse will be an incredible unlock with respect to efficiency and data liquidity and is a critical element of unlocking interoperability.

Furthermore, mandating standard APIs and data formats.

For clinical data.